Male birth control pill moves closer to reality
NCT ID NCT01382069
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new male hormone pill, dimethandrolone undecanoate (DMAU), as a potential daily contraceptive for men. Researchers gave single and repeated doses to 100 healthy men aged 18-50 to check safety and how the drug works in the body. The goal is to develop a reliable, hormone-based birth control option for men.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY MEN are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Los Angeles Biomedical Research Institute
Torrance, California, 90502, United States
-
University of Washington
Seattle, Washington, 98195, United States